These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28549530)

  • 1. The incidence of atypical femoral fractures in breast cancer patients with bone metastases who received bisphosphonate treatment.
    Nakata E; Sugihara S; Yamashita N; Osumi S
    J Orthop Sci; 2017 Sep; 22(5):946-950. PubMed ID: 28549530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.
    Zanchetta MB; Diehl M; Buttazzoni M; Galich A; Silveira F; Bogado CE; Zanchetta JR
    J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impending Atypical Femoral Fracture in a Patient of Breast Cancer With Bone Metastases Receiving Long-term Denosumab.
    Sugihara T; Koizumi M; Hayakawa K; Ito Y; Sata N
    Clin Nucl Med; 2018 May; 43(5):365-366. PubMed ID: 29517548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population.
    Cho YJ; Kang KC; Chun YS; Rhyu KH; Kim SJ; Jang TS
    Arch Osteoporos; 2018 May; 13(1):53. PubMed ID: 29725835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.
    Eisenstein N; Kasavkar G; Bhavsar D; Khan FS; Paskins Z
    BMC Musculoskelet Disord; 2017 Jan; 18(1):29. PubMed ID: 28114975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical femoral fracture associated with bone-modifying agent for bone metastasis of breast cancer: A report of two cases.
    Tateiwa D; Outani H; Iwasa S; Imura Y; Tanaka T; Oshima K; Naka N; Araki N
    J Orthop Surg (Hong Kong); 2017; 25(3):2309499017727916. PubMed ID: 28844196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes between older adults with atypical and typical femoral fractures are comparable.
    Khow KS; Paterson F; Shibu P; Yu SC; Chehade MJ; Visvanathan R
    Injury; 2017 Feb; 48(2):394-398. PubMed ID: 27839798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
    Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series.
    Andersen JD; Bünger MH; Rahbek O; Hald JD; Harsløf T; Langdahl BL
    Osteoporos Int; 2019 Feb; 30(2):513-517. PubMed ID: 30448959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
    Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
    Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical femur fracture during bisphosphonate drug holiday: a case series.
    Lovy AJ; Koehler SM; Keswani A; Joseph D; Hasija R; Ghillani R
    Osteoporos Int; 2015 Jun; 26(6):1755-8. PubMed ID: 25832177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
    Starr J; Tay YKD; Shane E
    Curr Osteoporos Rep; 2018 Aug; 16(4):519-529. PubMed ID: 29951870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea.
    Lee YK; Ahn S; Kim KM; Suh CS; Koo KH
    J Korean Med Sci; 2018 Jan; 33(5):e38. PubMed ID: 29349947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impending Atypical Femoral Fracture in Patients With Medullary Thyroid Cancer With Skeletal Metastasis Treated With Long-term Bisphosphonate and Denosumab.
    Koizumi M; Gokita T; Toda K
    Clin Nucl Med; 2017 Jun; 42(6):463-464. PubMed ID: 28240655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-related atypical femoral fracture with bone metastasis of breast cancer: case report and review.
    Hayashi K; Aono M; Shintani K; Kazuki K
    Anticancer Res; 2014 Mar; 34(3):1245-9. PubMed ID: 24596367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis.
    Ding X; Fan Y; Ma F; Li Q; Wang J; Zhang P; Yuan P; Xu B
    Breast; 2012 Aug; 21(4):544-9. PubMed ID: 22627092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.
    Meier RP; Perneger TV; Stern R; Rizzoli R; Peter RE
    Arch Intern Med; 2012 Jun; 172(12):930-6. PubMed ID: 22732749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Incidence of Atypical Femoral Fractures in Patients with Rheumatic Disease: Yamagata Prefectural Committee of Atypical Femoral Fractures (YamaCAFe) Study.
    Takakubo Y; Ohta D; Ishi M; Ito J; Oki H; Naganuma Y; Uno T; Sasaki A; Akabane T; Dairaku K; Goto S; Goto Y; Kanauchi Y; Kobayashi S; Nakajima T; Masuda K; Matsuda M; Mura N; Takenouchi K; Tsuchida H; Onuma Y; Shibuya J; Seino M; Yamaguchi O; Hiragami K; Urayama Y; Furukawa T; Okuda S; Ogura K; Nakamura T; Sasaki K; Konta T; Takagi M
    Tohoku J Exp Med; 2017 Aug; 242(4):327-334. PubMed ID: 28883214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Sato H; Kondo N; Wada Y; Nakatsue T; Iguchi S; Fujisawa J; Kazama JJ; Kuroda T; Nakano M; Endo N; Narita I
    Osteoporos Int; 2016 Mar; 27(3):1217-1225. PubMed ID: 26519417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Atypical Features of Femur Fractures: How Change in Radiological Criteria Influenced Incidence and Demography of Atypical Femur Fractures in a Community Setting.
    LeBlanc ES; Rosales AG; Black DM; Genant HK; Dell RM; Friess DM; Boardman DL; Bauer DC; de Papp A; Santora AC; Orwoll ES
    J Bone Miner Res; 2017 Nov; 32(11):2304-2314. PubMed ID: 28731209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.